Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,747
Closed -$34K 2331
2022
Q4
$34K Hold
2,747
﹤0.01% 2159
2022
Q3
$22K Hold
2,747
﹤0.01% 2251
2022
Q2
$32K Hold
2,747
﹤0.01% 2163
2022
Q1
$49K Buy
2,747
+1,268
+86% +$34.5K ﹤0.01% 2166
2021
Q4
$63K Sell
1,479
-270
-15% -$13.2K ﹤0.01% 2116
2021
Q3
$92K Buy
1,749
+560
+47% +$26.9K ﹤0.01% 2071
2021
Q2
$54K Hold
1,189
﹤0.01% 2249
2021
Q1
$52K Buy
1,189
+687
+137% +$30.1K ﹤0.01% 2283
2020
Q4
$19K Hold
502
﹤0.01% 2549
2020
Q3
$16K Buy
502
+412
+458% +$15.9K ﹤0.01% 2481
2020
Q2
$4K Hold
90
﹤0.01% 2620
2020
Q1
$3K Buy
+90
New +$4.95K ﹤0.01% 2618

Other funds holding VEON

Canada Life's VEON Position: Q1 2023 in Review

Canada Life sold out of VEON (VEON) in Q1 2023, closing a stake of 2,747 shares — an estimated $34K sold.

Canada Life first reported a position in VEON in Q1 2020 and held it in 12 quarters. The position peaked at $92K in Q3 2021. 41 funds tracked by Wall St. Rank hold VEON as of Q1 2023.

  • Canada Life reported no remaining VEON position as of Q1 2023 after selling out during the quarter.
  • Canada Life sold 2,747 VEON shares in Q1 2023, an estimated $34K.
  • Canada Life first reported a position in VEON in Q1 2020 and held it in 12 quarters.
  • Canada Life's VEON position peaked at $92K in Q3 2021.
  • 41 funds tracked by Wall St. Rank held VEON as of Q1 2023.

Based on Canada Life's 13F filing for Q1 2023, filed 12 May 2023.